Keywords: emea, restricts, use, millennium/j, velcade, european, medicines

EMEA restricts use of Millennium/J&J's Velcade

Article | 31 March 2008

The European Medicines Agency (EMEA) has recommended that Millennium and partner Johnson & Johnson's multiple myeolma drug Velcade (bortezomib) should not ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Johnson & Johnson

Go to company listing

Related Drugs

bortezomib

Velcade

Go to drug listing